MIC appoints Frederick as CEO

Molecular Imaging Corporation (MIC) has named Kenneth Frederick as CEO. Frederick has served on the Board of the Company since June.

Frederick's experience includes the creation and implementation of business strategy and commercialization of new markets for Symmorphix Inc. of Sunnyvale, Calif., a spin-off of Applied Materials Inc. of Santa Clara, Calif. While at Picarro, he focused on developing and executing alternative business models and partnerships in the industrial and medical diagnostic instruments markets, MIC said. At Stratum Technologies, Frederick led the expansion of web-based operating software for the oncology healthcare segment and other new markets. Frederick also worked over 26 years for Raychem Corp. where held a variety of senior positions.

Around the web

The nuclear imaging isotope shortage of molybdenum-99 may be over now that the sidelined reactor is restarting. ASNC's president says PET and new SPECT technologies helped cardiac imaging labs better weather the storm.

CMS has more than doubled the CCTA payment rate from $175 to $357.13. The move, expected to have a significant impact on the utilization of cardiac CT, received immediate praise from imaging specialists.

The newly cleared offering, AutoChamber, was designed with opportunistic screening in mind. It can evaluate many different kinds of CT images, including those originally gathered to screen patients for lung cancer. 

Trimed Popup
Trimed Popup